| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC2900 |
| Trial ID | NCT05201118 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CT103A |
| Co-treatment | Selinexor |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma |
| Year | 2022 |
| Country | China |
| Company sponsor | Chunrui Li |
| Other ID(s) | CAR CT103A SELINEXOR001 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||